Monitor for any prospectus supplement or takedown announcement under the shelf, which would signal an imminent offering and likely near-term price pressure. The shelf itself is a neutral procedural event with no immediate trading catalyst.
Price Chart
Executive Summary
Nasus Pharma Ltd's shelf registration (F-3) on Form 333-298693 became effective on September 11, 2026, allowing the company to offer and sell securities from time to time. This creates a potential dilution overhang for the common stock, though no immediate offering has been announced. The effectiveness is a routine procedural step, but the shelf enables future capital raises that could pressure the stock.
Key Facts
- Shelf registration on Form 333-298693 became effective on September 11, 2026.
- Nasus Pharma can now offer and sell securities (common stock, preferred stock, warrants, units) at its discretion.
- No specific offering size, pricing, or timing has been disclosed in this filing.
- The shelf registration is filed under the Securities Act of 1933.
Financial Impact
Potential future dilution from any offering under the shelf; no current offering terms disclosed.
Risk Factors
- Future equity offering could dilute existing shareholders.
- No disclosure of intended use of proceeds or timing of any offering.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002954 |
| Document: 9999999995-26-002954-index.html | 9999999995-26-002954 |
| Document: 9999999995-26-002954.txt | 9999999995-26-002954 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 6-K | $3.51 | awaiting T+20 | — | $3.40 (−2.99%) |
Sep 23, 2026 4w ago | 3 | $3.64 $3.06 | ▼ −15.93% | ▼ −16.62% | $3.40 (−6.46%) |
Sep 18, 2026 5w ago | 424B5 | $3.44 $3.21 | ▲ +6.83% | ▲ +5.92% | $3.40 (+1.02%) |
Sep 14, 2026 6w ago | 6-K | $3.65 $3.32 | ▼ −9.04% | ▼ −11.30% | $3.40 (−6.71%) |
Sep 14, 2026 6w ago | EFFECT | $3.65 $3.32 | ▼ −9.04% | ▼ −11.30% | $3.40 (−6.71%) |
Aug 21, 2026 9w ago | EFFECT | $4.00 $3.44 | ▼ −14.00% | ▼ −13.47% | $3.40 (−14.88%) |
Aug 19, 2026 9w ago | 6-K | $3.84 $3.53 | ▼ −8.07% | ▼ −6.12% | $3.40 (−11.33%) |
Aug 17, 2026 10w ago | 6-K | $3.70 $3.59 | ▼ −2.97% | ▼ −1.00% | $3.40 (−7.97%) |
Aug 17, 2026 10w ago | Press Release | $3.70 $3.59 | ▼ −2.97% | ▼ −1.00% | $3.40 (−7.97%) |
Apr 1, 2026 29w ago | EFFECT | $2.55 $2.56 | ▼ −0.39% | ▲ +9.33% | $3.40 (−33.53%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers